These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 31262819)
1. Cell-autonomous FLT3L shedding via ADAM10 mediates conventional dendritic cell development in mouse spleen. Fujita K; Chakarov S; Kobayashi T; Sakamoto K; Voisin B; Duan K; Nakagawa T; Horiuchi K; Amagai M; Ginhoux F; Nagao K Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14714-14723. PubMed ID: 31262819 [TBL] [Abstract][Full Text] [Related]
2. Identification of dendritic cell precursor from the CD11c In H; Park JS; Shin HS; Ryu SH; Sohn M; Choi W; Park S; Hwang S; Park J; Che L; Kim TG; Chu MK; Na HY; Park CG Front Immunol; 2023; 14():1179981. PubMed ID: 38094300 [TBL] [Abstract][Full Text] [Related]
3. Posttranslational modifications by ADAM10 shape myeloid antigen-presenting cell homeostasis in the splenic marginal zone. Diener N; Fontaine JF; Klein M; Hieronymus T; Wanke F; Kurschus FC; Ludwig A; Ware C; Saftig P; Bopp T; Clausen BE; Backer RA Proc Natl Acad Sci U S A; 2021 Sep; 118(38):. PubMed ID: 34526403 [TBL] [Abstract][Full Text] [Related]
4. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells. Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189 [TBL] [Abstract][Full Text] [Related]
5. ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Damle SR; Martin RK; Cockburn CL; Lownik JC; Carlyon JA; Smith AD; Conrad DH Allergy; 2018 Jan; 73(1):125-136. PubMed ID: 28745029 [TBL] [Abstract][Full Text] [Related]
6. Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage. Bajana S; Thomas K; Georgescu C; Zhao Y; Wren JD; Kovats S; Sun XH Front Immunol; 2020; 11():577718. PubMed ID: 33391258 [TBL] [Abstract][Full Text] [Related]
7. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage. Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Shackleton B; Crawford F; Bachmeier C Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17. Alabi RO; Lora J; Celen AB; Maretzky T; Blobel CP Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673337 [TBL] [Abstract][Full Text] [Related]
10. Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10. Hammad H; Vanderkerken M; Pouliot P; Deswarte K; Toussaint W; Vergote K; Vandersarren L; Janssens S; Ramou I; Savvides SN; Haigh JJ; Hendriks R; Kopf M; Craessaerts K; de Strooper B; Kearney JF; Conrad DH; Lambrecht BN Nat Immunol; 2017 Mar; 18(3):313-320. PubMed ID: 28068307 [TBL] [Abstract][Full Text] [Related]
11. The metalloproteinase ADAM10 requires its activity to sustain surface expression. Seifert A; Düsterhöft S; Wozniak J; Koo CZ; Tomlinson MG; Nuti E; Rossello A; Cuffaro D; Yildiz D; Ludwig A Cell Mol Life Sci; 2021 Jan; 78(2):715-732. PubMed ID: 32372373 [TBL] [Abstract][Full Text] [Related]
12. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding. Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679 [TBL] [Abstract][Full Text] [Related]
13. A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development. Toonen JA; Ronchetti A; Sidjanin DJ PLoS One; 2016; 11(5):e0156184. PubMed ID: 27224017 [TBL] [Abstract][Full Text] [Related]
14. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17. Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870 [TBL] [Abstract][Full Text] [Related]